Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma

NCT07460245 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Avelumab 800 mg flat-dose IV

Sponsor

Gruppo Oncologico Italiano di Ricerca Clinica